Systematic review with meta-analysis of diagnostic test accuracy for COVID-19 by mass spectrometry.
Systematic review with meta-analysis of diagnostic test accuracy for COVID-19 by mass spectrometry.
复制标题
DOI:
10.1016/j.metabol.2021.154922
复制
发表时间:
2022-01
期刊:
影响因子:
--
通讯作者:
Bailey MJ
中科院分区:
文献类型:
--
作者:
Spick M;Lewis HM;Wilde MJ;Hopley C;Huggett J;Bailey MJ
The global COVID-19 pandemic has led to extensive development in many fields, including the diagnosis of COVID-19 infection by mass spectrometry. The aim of this systematic review and meta-analysis was to assess the accuracy of mass spectrometry diagnostic tests developed so far, across a wide range of biological matrices, and additionally to assess risks of bias and applicability in studies published to date. 23 retrospective observational cohort studies were included in the systematic review using the PRISMA-DTA framework, with a total of 2858 COVID-19 positive participants and 2544 controls. Risks of bias and applicability were assessed via a QUADAS-2 questionnaire. A meta-analysis was also performed focusing on sensitivity, specificity, diagnostic accuracy and Youden's Index, in addition to assessing heterogeneity. Sensitivity averaged 0.87 in the studies reviewed herein (interquartile range 0.81–0.96) and specificity 0.88 (interquartile range 0.82–0.98), with an area under the receiver operating characteristic summary curve of 0.93. By subgroup, the best diagnostic results were achieved by viral proteomic analyses of nasopharyngeal swabs and metabolomic analyses of plasma and serum. The performance of other sampling matrices (breath, sebum, saliva) was less good, indicating that these protocols are currently insufficiently mature for clinical application. This systematic review and meta-analysis demonstrates the potential for mass spectrometry and ‘omics in achieving accurate test results for COVID-19 diagnosis, but also highlights the need for further work to optimize and harmonize practice across laboratories before these methods can be translated to clinical applications. Mass spectrometry complements RT-PCR in COVID-19 diagnostics. Meta-analysis of mass spectrometry diagnostics for COVID-19 shows accuracy of 87%. Diagnosis in admissions settings is a promising use-case for mass spectrometry. Future work should focus on validating features and protocols across laboratories.
登录
查看更多内容
DOI:
10.1016/j.trac.2021.116328
发表时间:
2021-09
期刊:
Trends in analytical chemistry : TRAC
影响因子:
--
作者:
Griffin JH;Downard KM
通讯作者:
Downard KM
影响因子:
4.4
作者:
Kimhofer, Torben;Lodge, Samantha;Nicholson, Jeremy K.
通讯作者:
Nicholson, Jeremy K.
影响因子:
7.4
作者:
Delafiori J;Navarro LC;Siciliano RF;de Melo GC;Busanello ENB;Nicolau JC;Sales GM;de Oliveira AN;Val FFA;de Oliveira DN;Eguti A;Dos Santos LA;Dalçóquio TF;Bertolin AJ;Abreu-Netto RL;Salsoso R;Baía-da-Silva D;Marcondes-Braga FG;Sampaio VS;Judice CC;Costa FTM;Durán N;Perroud MW;Sabino EC;Lacerda MVG;Reis LO;Fávaro WJ;Monteiro WM;Rocha AR;Catharino RR
通讯作者:
Catharino RR
影响因子:
8.4
作者:
Amzat, Jimoh;Aminu, Kafayat;Danjibo, Maryann C.
通讯作者:
Danjibo, Maryann C.
DOI:
10.1016/j.jmsacl.2021.09.001
发表时间:
2021-08
影响因子:
2.2
作者:
Chivte P;LaCasse Z;Seethi VDR;Bharti P;Bland J;Kadkol SS;Gaillard ER
通讯作者:
Gaillard ER